Polymorphisms in the microsomal epoxide hydrolase gene: Role in lung cancer susceptibility and prognosis

Tumori

Volumn 96, Issue 5, 2010, Pages 756-763

  Erkisi, Zelal ^a   Yaylim Eraltan, Ilhan ^a   Turna, Akif ^b   Görmüs, Uzay ^a   Camlica, Hakan ^a   Isbir, Turgay ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Yedikule Teaching Hospital   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Exons 3 and 4 polymorphism; Lung cancer; Metastasis; Microsomal epoxide hydrolase

Indexed keywords

EPOXIDE HYDROLASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 78650491074     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600519     Document Type: Article

References (38)

1. Zusterzeel PLM, Peters WHM, Visser W, Hermsen KJM, Roelofs HMJ, Steegers EAP: A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J Med Genet, 38: 234-237, 2001. (Pubitemid 32324505)
2. Zhang JH, Jin X, Li Y, Wang R, Guo W, Wang N, Wen DG, Chen ZF, Kuang G, Wei LZ, Wang SJ. Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China. World J Gastroenterol, 9: 2654-2657, 2003.
3. Oesch F: Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica, 3: 305-340, 1973.
4. Seidegard J, DePierre JW: Microsomal epoxide hydrolase. Properties, regulation and function. Biochim Biophys Acta, 695: 251-270, 1983.
5. Wang P, Meijer J, Guengerich FP: Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme. Biochemistry, 21: 5769-5776, 1982.
6. Omiecinski CJ, Aicher L, Holubkov R, Checkoway H: Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogentics, 3: 150-158, 1993. (Pubitemid 23175568)
7. Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P: Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer, 33: 133-141, 2001. (Pubitemid 32707894)
8. Raaka S, Hassett C, Omiecinski CJ: Human microsomal epoxide hydrolase: 5′-flanking region genetic polymorphisms. Carcinogenesis, 19: 387-393, 1998. (Pubitemid 28375439)
9. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet, 3: 421-428, 1994. (Pubitemid 24083901)
10. Wu X, Gwyn K, Amos CI, Makan N, Hong WK, Spitz MR: The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis, 22: 6923-6928, 2001.
11. Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P, Mohn-Staudner A, Armbruster C, Madersbacher S, Schatzl G, Trieb K, Vutuc C, Micksche M: Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer, 89: 702-706, 2003.
12. Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L, Ingelman-Sundberg M: Genetic polymorphism of xenobiotic metabolising enzymes among Chinese lung cancer patients. Int J Cancer, 81: 325-329, 1999.
13. rd ed, Springer Verlag, Berlin-Heidelberg, 1999.
14. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16: 1215, 1988.
15. Lin YC, Wu DC, Lee JM, Hsu HK, Kao EL, Yang CH, Wu MT: The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking. Cancer Lett, 237: 281-288, 2006.
16. Smith CAD, Harrison DJ: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet, 350: 630-633, 1997. (Pubitemid 27367797)
17. Croce CM. Oncogenes and cancer. N Engl J Med, 358: 502-511, 2008.
18. Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis. Int J Med Sci, 4: 59-71, 2007. (Pubitemid 46238636)
19. Mattson ME, Pollack ES, Cullen JW: What are the odds that smoking will kill you? Am J Public Health, 77: 425, 1987.
20. Hirvonen A: Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect, 107: 37-47, 1999.
21. Gonzalez FJ, Samore M, McQuiddy P, Kasper CB: Effects of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene on the cellular levels of epoxide hydratase, cytochrome P-450b, and NADPH-cytochrome c (P-450) oxidoreductase messenger ribonucleic acids. J Biol Chem, 257: 11032-11036, 1982.
22. Jerina DM: The 1982 Bernard B. Brodie Award Lecture. Metabolism of aromatic hydrocarbons by the cytochrome P-450 systemand epoxide hydrolase. Drug Metab Dispos, 11: 1-4, 1983.
23. London SJ, Smart J, Daly AK: Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer, 28: 147-155, 2000. (Pubitemid 30136414)
24. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Corbella J: Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione-s-transferase P1. Cancer Lett, 173: 155-162, 2001. (Pubitemid 32971933)
25. Bartsch H, Nair U, Risch A, Rojas M, Wilkman H, Alexandrov K: Genetic polymorphism of CYP genes, alone or in combination, as a riskmodifier of tobacco related cancers. Cancer Epidemiol Biomarkers Prev, 9: 3-28, 2000.
26. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A: Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res, 58: 5291-5293, 1998.
27. Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, Mezetti M, Cappelli R, Panigalli T, Fanelli R, Airoldi L: Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a) pyrene-diolepoxide. Cancer Epidemiol Biomarkers Prev, 7: 703-709, 1998.
28. Petruzzelli S, Camus AM, Carozzi L, Ghelarducci L, Rindi M, Menconi G, Angeletti CA, Ahotupa M, Hietanen E, Aitio A, Saracci R, Bartsch H, Giuntini C: Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case control study on lung cancer patients. Cancer Res, 48: 4695-4700, 1988.
29. Zhou W, Thurston SW, Liu G, Xu L, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC: The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev, 10: 461-466, 2001.
30. Habalova V, Salagovic J, Kalina I, Stubna J: Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients. Neoplasma, 51: 352-357, 2004. (Pubitemid 39486108)
31. Lin P, Wang SL, Wanh HJ, Chen KW, Lee HS, Tsai KJ, Chen CY, Lee H: Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br J Cancer, 82: 852-857, 2000. (Pubitemid 30085238)
32. Tsai Y, McGlynn KA, Hu Y, Cassidy AB, Arnold J, Engstrom PF, Buetow KH: Genetic susceptibility and dietary patterns in lung cancer. Lung Cancer, 41: 269-281, 2003. (Pubitemid 36970183)
33. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y: EPHX1 polymorphisms and the risk of lung cancer. A HuGE Review. Epidemiology, 17:89-99, 2006.
34. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Paré PD: Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med, 163: 469-473, 2001. (Pubitemid 32158530)
35. Rusch VW, Crowley J, Giroux DJ, Goldstraw P, Im JG, Tsuboi M, Tsuchiya R, Vansteenkiste J: The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol, 2: 603-612, 2007. (Pubitemid 47171781)
36. Demir A, Altin S, Pehlivan D, Demir M, Yakar F, Seyhan EC, Dincer SI: The role of GSTM1 gene polymorphisms in lung cancer development in Turkish population. J Carcinogenesis, 7: 13, 2007.
37. Ada AO, Suzen HS, Iscan M: Polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1 in a male Turkish population. Int J Toxicol, 26: 41-46, 2007.
38. Pinarbasi E, Percin FE, Yilmaz M, Akgun E, Cetin M, Çetin A: Association of microsomal epoxide hydrolase gene polymorphism and pre-eclampsia in Turkish women. J Obstet Gynaecol Res, 33: 32-37, 2007.